Pharmacologic therapeutic options for thromboprophylaxis in COVID-19.

Kow, Chia Siang; Hasan, Syed Shahzad

Kow, Chia Siang; Hasan, Syed Shahzad.

Kow CS; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. chiasiang_93@hotmail.com.
Hasan SS; School of Applied Sciences, University of Huddersfield, Huddersfield, UK.

J Thromb Thrombolysis ; 51(1): 29-30, 2021 Jan.

Article in English | MEDLINE | ID: covidwho-617345

Subject(s)

Anticoagulants; COVID-19; Chemoprevention; Venous Thromboembolism; Anticoagulants/administration & dosage; Anticoagulants/classification; COVID-19/blood; COVID-19/complications; COVID-19/therapy; Chemoprevention/methods; Chemoprevention/standards; Critical Illness/therapy; Drug Administration Routes; Humans; Patient Selection; SARS-CoV-2; Ultrasonography, Doppler, Duplex/methods; Venous Thromboembolism/diagnosis; Venous Thromboembolism/etiology; Venous Thromboembolism/prevention & control

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Chemoprevention / Venous Thromboembolism / COVID-19 / Anticoagulants Type of study: Diagnostic study Topics: Long Covid Limits: Humans Language: English Journal: J Thromb Thrombolysis Journal subject: Vascular Diseases Year: 2021 Document Type: Article Affiliation country: S11239-020-02200-w

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google